Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
about
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenIntragraft selection of the T cell receptor repertoire by class I MHC sequences in tolerant recipientsPredicting alloreactivity in transplantation.Mechanisms of chronic rejection in cardiothoracic transplantation.Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allograftsOn the crossroad between tolerance and posttransplant lymphoma.Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathyEpitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.The major histocompatibility complex in transplantationEfficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.Allopeptides and the alloimmune response.Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants.Pathways of major histocompatibility complex allorecognition.Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.Essential concept of transplant immunology for clinical practiceRole of T cells in graft rejection and transplantation tolerance.Cell therapy to promote transplantation tolerance: a winning strategy?Immune recognition and rejection of allogeneic skin grafts.The importance of non-HLA antibodies in transplantation.Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft RejectionInduction of immunologic tolerance for transplantation.Role of endothelial cells in allograft rejection.Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants.Innate immunity and resistance to tolerogenesis in allotransplantationAlloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.Humoral Epitope Spreading in Autoimmune Bullous Diseases.T cell Allorecognition Pathways in Solid Organ Transplantation
P2860
Q26766411-F23E38EC-C9B9-446C-A9DE-CAE700D851C3Q33475648-E31676FD-34FB-4871-890D-FC297C410B25Q33608371-A9DE095D-476C-419B-A195-61DB2E86096DQ33841493-216AADB9-A066-42C3-80F4-7866580D43BCQ33993731-B727A358-0387-4621-946C-D16CA83E0AE4Q34221228-C68B7F37-AB9F-4DEA-BC5C-3A7DA0636253Q34406874-32D60F7D-0B22-4347-A3BB-D01E2C46EDABQ34721121-47FE899E-E072-4488-91FE-B0C23BA72880Q35050517-EB12606F-5641-4698-96D7-D8848366A48CQ35127578-E6F7CBAF-6188-4E62-843E-A0EE5FFA9B71Q35655762-831BFCB5-71C3-46DB-9D5B-54D7AC3CA22FQ35691658-DF6B9663-0224-4E9B-A4DF-9F8D27F43637Q36072165-F3DB8D20-0357-482F-BE7C-B97D3AE22064Q36401207-42BF27BB-16C5-4CC3-A1FD-E898028A79C5Q36600237-E0287009-2D78-487F-A4E1-97D5381DF5DAQ36976110-B82615E5-B532-4006-92C1-2096E9435B1DQ37006610-8AE15AB5-9066-41FD-95D0-209C30C27562Q37232364-E5D772EB-A324-43F6-B1BD-ABC3B6CD3AA3Q37236992-5306EFAC-262D-4611-BEDD-EEE5610755CEQ37377561-CCE00FD7-2A8F-4D70-AEAA-24607ECFF25CQ37384050-1B3575F2-68F4-454B-A263-FD75A80EE6B1Q37428551-304CC7C3-13E9-48FD-897D-7F1CE50C0BCAQ37729059-F571CC23-F3DE-4B8A-B4BB-79BBFAD41E99Q37869488-2601F55F-ECFF-497B-BA62-1FF32B352CD7Q37888686-D74820E9-5E77-41D8-B71E-53B2795F556AQ38877375-6C76E72C-1831-4323-9BD8-01A58F62FCA4Q39121365-4FD2CB73-E75D-4613-AA4B-A1ACA3166BEEQ40827011-7C98CABC-ED56-497E-8AC3-F06A9E87B295Q41740428-CE2E73E8-5F40-46B6-B987-579A0C5D1D04Q41899266-DE768A00-2CC3-48E7-954F-9C874BEAA66DQ42025217-10EA1793-0FDD-4839-B5BD-150DA597FAADQ47265853-03FDE94A-ACA5-4707-9CC0-FE947E1944CCQ55262188-F26940C9-1585-417D-B9E2-396868AF34F7Q59130097-70362ED2-54A6-4C01-95FF-9A5F92107617
P2860
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@en
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@nl
type
label
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@en
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@nl
prefLabel
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@en
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@nl
P2093
P2860
P356
P1476
Indirect recognition of donor HLA-DR peptides in organ allograft rejection.
@en
P2093
A I Colovai
N Suciu-Foca
P E Fisher
R Cortesini
R E Michler
P2860
P304
P356
10.1172/JCI118898
P407
P577
1996-09-01T00:00:00Z